CTI BioPharma
CTIC
#5622
Rank
$1.19 B
Marketcap
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)

CTI BioPharma (CTIC) - Cash on Hand

Cash on Hand as of March 2023 : $59.01 Million USD

According to CTI BioPharma 's latest financial reports the company has $59.01 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CTI BioPharma - Cash on Hand chart (from 1997 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$79.93 M22.14%
2021-12-31$65.44 M24.78%
2020-12-31$52.45 M55.8%
2019-12-31$33.66 M-49.78%
2018-12-31$67.03 M55.12%
2017-12-31$43.21 M-1.78%
2016-12-31$44 M-65.67%
2015-12-31$0.12 B80.71%
2014-12-31$70.93 M-0.99%
2013-12-31$71.63 M42.04%
2012-12-31$50.43 M7.19%
2011-12-31$47.05 M107.74%
2010-12-31$22.64 M-40.1%
2009-12-31$37.81 M254.33%
2008-12-31$10.67 M-41.83%
2007-12-31$18.34 M-65.92%
2006-12-31$53.83 M-21.84%
2005-12-31$68.88 M-40.56%
2004-12-31$0.11 B26.52%
2003-12-31$91.58 M-34.7%
2002-12-31$0.14 B-45.2%
2001-12-31$0.25 B65.22%
2000-12-31$0.15 B548.15%
1999-12-31$23.9 M443.18%
1998-12-31$4.4 M-50.56%
1997-12-31$8.9 M61.82%
1996-12-31$5.5 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
$9.44 B 15,905.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$16.50 B 27,864.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
$2.92 B 4,864.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
$1.72 B 2,824.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$9.91 B 16,699.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$2.20 B 3,633.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
$9.75 B 16,427.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland